Medtronic plc (NYSE:MDT) Q4 2024 Earnings Conference Call May 23, 2024 8:00 AM ET
Company Participants
Ryan Weispfenning - Vice President and Head, Investor Relations
Geoff Martha - Chairman and Chief Executive Officer
Karen Parkhill - Executive Vice President and Chief Financial Officer
Brad Welnick - Vice President, Investor Relations
Sean Salmon - Executive Vice President and President, Cardiovascular Portfolio
Brett Wall - Executive Vice President and President, Neuroscience Portfolio
Mike Marinaro - Executive Vice President and President, Medical Surgical Portfolio and Surgical Operating Unit
Que Dallara - Executive Vice President and President, Diabetes Operating Unit
Conference Call Participants
Travis Steed - Bank of America Securities
Robert Marcus - JPMorgan
Vijay Kumar - Evercore ISI
Lawrence Biegelsen - Wells Fargo
Pito Chickering - Deutsche Bank
Joshua Jennings - Cowen and Company
Richard Newitter - Truist Securities
Matt Miksic - Barclays
Ryan Weispfenning
Good morning. I'm Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations and I appreciate that you're joining us this morning for our Fiscal '24 Fourth Quarter Video Earnings Webcast. Before we go inside to hear our prepared remarks, I'll share a few details about today's webcast.
Joining me are Geoff Martha, Medtronic Chairman and Chief Executive Officer; and Karen Parkhill, Medtronic Chief Financial Officer. Geoff and Karen will provide comments on the results of our fourth quarter and fiscal year 2024, which ended on April 26th, 2024, and our outlook for fiscal year '25. After our prepared remarks, the Executive VPs covering our segments will join us and we'll take questions from the sell-side analysts that cover the company. Today's program should last about an hour.
Earlier this morning, we issued a press release containing our financial achievements and divisional and geographic revenue summaries. We also posted an earnings presentation that provides additional details on our performance. The presentation can be accessed in our earnings press release or on our website at investorrelations.medtronic.com.
During today's program, many of the statements we make may be considered forward-looking statements. And actual results may differ materially from those projected in any forward-looking statements. Additional information concerning factors that could cause actual results to differ is contained in our periodic reports and other filings that we make with the SEC. And we do not undertake to update any forward-looking statements.
Unless we say otherwise, all comparisons are on a year-over-year basis, and revenue comparisons are made on an organic basis, which excludes the impact of foreign currency, prior year revenue from a one-time IP agreement in Structural Heart and fourth quarter revenue in the current and prior year reported as other, which stems from prior business separations. There were no acquisitions made in the last four quarters that had a significant impact on total company or individual segment quarterly revenue growth.